Exposures to different SARS-CoV-2 spike variants elicit neutralizing antibody responses with differential specificity towards established and emerging strains

Matthew T Laurie; Jamin Liu; Sara Sunshine; James Peng; Douglas Black; Anthea M Mitchell; Sabrina A Mann; Genay Pilarowski; Kelsey C Zorn; Luis Rubio; Sara Bravo; Joseph J Sabatino; Kristen Mittl; Carina Marquez; Maya Petersen; Diane Havlir; Joseph DeRisi.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-21263095

Documentos relacionados

  1. SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron.
  2. SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and Omicron.
  3. SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8<sup>+</sup> T cells.
  4. Interferon resistance of emerging SARS-CoV-2 variants.
  5. Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
  6. T cell responses to SARS-CoV-2 spike cross-recognize Omicron.
  7. Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants.
  8. SARS-CoV-2 Evolution and Patient Immunological History Shape the Breadth and Potency of Antibody-Mediated Immunity.
  9. Memory CD8<sup>+</sup> T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination.
  10. Divergent Antibody Repertoires Found for Omicron versus Wuhan SARS-CoV-2 Strains Using Ig-MS.